Get startedLog in
    Picture of PCI Biotech Holding ASA logo

    PCIBo — PCI Biotech Holding ASA News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapNeutral
    All News

    Brief: PCI Biotech: Orphan Drug Designation for fimaporfin

    Picture of PCI Biotech Holding ASA logoPCI Biotech Holding ASA
    29/08/2016 20:48
    Aug 30(Reuters) - PCI Biotech Holding ASA  PCIB.OL : 
    * Said on Monday European Commission granted Orphan Drug Designation for fimaporfin for 
treatment of cholangiocarcinoma  
    * Orphan designation provides 10 years market exclusivity for product upon approval, among 
others 
 
     
 Source text for Eikon:  urn:newsml:reuters.com:*:nGNE1LYWmj 
     
 Further company coverage:  PCIB.OL   
    
 
 
 (Gdynia Newsroom) 
 ((Gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))

    Recent news on PCI Biotech Holding ASA

    See all news